Hospitals adjust expenditures to be a constant proportion of their revenues. An unexpected 10-percent change in hospital revenue generates a 3.5-4.8 percent expenditure change (in the same direction) the year it occurs, with declining changes thereafter (10 percent in total). Non-profit and government hospitals adjust expenditures about 80 percent of the way toward their longrun change near the...

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269 6.8 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235 5.9 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227 5.7 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184 4.7 20 to 24 years . . . . . . . . . . . . . . . . . . . . ....

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134 8.4 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141 8.9 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139 8.7 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143 9.0 20 to 24 years . . . . . . . . . . . . . . . . . . . . ....

What’s the best thing about HHMI funding? There's lots of it. The annual HHMI budget was $330 million in 1994, of which about 80 % was spent on the 227 HHMI investigators. For those who need lots of money for mice or equipment, HHMI funding can be the answer to a prayer. And HHMI, unlike most other funding bodies, does not discourage long-term, risky research or projects with little obvious rel...

http://iac.dtic.mil/iatac Configuration complexity imposes a heavy burden on both regular users and experienced administrators. This complexity dramatically reduces overall network assurability. For example, a report from the Center for Strategic and International Studies states that “inappropriate or incorrect security configurations were responsible for 80 percent of United States Air Force v...

BACKGROUND Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, is a potential alternative to allopurinol for patients with hyperuricemia and gout. METHODS We randomly assigned 762 patients with gout and with serum urate concentrations of at least 8.0 mg per deciliter (480 micromol per liter) to receive either febuxostat (80 mg or 120 mg) or allopurinol (300 mg) once daily f...